CVS - CVS HEALTH Corp


64.93
-0.390   -0.601%

Share volume: 7,695,220
Last Updated: 04-28-2025
Retail/Retail – Drug & Proprietary Stores: 0.06%

PREVIOUS CLOSE
CHG
CHG%

$65.32
-0.39
-0.01%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
34%
Profitability 32%
Dept financing 25%
Liquidity 10%
Performance 45%
Company vs Stock growth
vs
95.428 B 97.710 B
2.282 B 2.39%
61.610 63.220
1.610 2.61%
Performance
5 Days
-1.50%
1 Month
-4.16%
3 Months
14.11%
6 Months
15.43%
1 Year
-3.74%
2 Year
-12.13%
Key data
Stock price
$64.93
P/E Ratio 
12.09
DAY RANGE
$64.20 - $66.15
EPS 
$3.67
52 WEEK RANGE
$43.56 - $71.45
52 WEEK CHANGE
-$4.11
MARKET CAP 
55.781 B
YIELD 
6.00%
SHARES OUTSTANDING 
1.258 B
DIVIDEND
$0.665
EX-DIVIDEND DATE
04-22-2025
NEXT EARNINGS DATE
05-01-2025
BETA 
0.71
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$8,230,679
AVERAGE 30 VOLUME 
$11,370,227
Company detail
CEO: Karen S. Lynch
Region: US
Website: cvshealth.com
Employees: 300,000
IPO year: 1984
Issue type: Common Stock
Market: NYSE
Industry: Retail/Retail – Drug & Proprietary Stores
Sector: Retail Trade

CVS Health Corporation provides health services in the United States. Its Pharmacy Services segment offers pharmacy benefit management solutions. Retail/LTC segment sells prescription and over-the-counter drugs, consumer health and beauty products, and personal care products. The company operates approximately 9,900 retail locations and 1,200 MinuteClinic locations.

Recent news

Gear Up for CVS Health (CVS) Q1 Earnings: Wall Street Estimates for Key Metrics

Evaluate the expected performance of CVS Health (CVS) for the quarter ended March 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.

Read more

Stocks to watch next week: Apple, Microsoft, Shell, HSBC, Lloyds and AstraZeneca

Earnings preview of key companies reporting next week and what to look out for.

Read more

CVS Health (CVS) Earnings Expected to Grow: Should You Buy?

CVS Health (CVS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Read more